|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/1767 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) |
| (11) | Number of the document | 3612208 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18726731.5 |
| Date of filing the European patent application | 2018-04-20 | |
| (97) | Date of publication of the European application | 2020-02-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/060241 |
| Date | 2018-04-20 |
| (87) | Number | WO 2018/193122 |
| Date | 2018-10-25 |
| (30) | Number | Date | Country code |
| 201706404 | 2017-04-21 | GB | |
| 201706406 | 2017-04-21 | GB | |
| 201706452 | 2017-04-24 | GB |
| (72) |
NUNN, Miles Andrew , CH
ABHYANKAR, Brihad , CH
SADIK, Christian David , DE
|
| (73) |
Volution Immuno Pharmaceuticals SA ,
Place Des Eaux Vives 6
Case Postale 3461, 1211 Genève 3,
CH
|
| (54) | COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES |
| COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES |